Schedule of Earnings Per Share |
The
following table sets forth the computation of the Company’s basic and diluted net loss per share available to common stockholders
during the years ended December 31, 2021 and 2020:
Schedule of Earnings Per Share
|
|
2021 |
|
|
2020 |
|
|
|
Year Ended December 31, |
|
|
|
2021 |
|
|
2020 |
|
Numerator |
|
|
|
|
|
|
|
|
Net loss from continuing operations |
|
$ |
(5,272,373 |
) |
|
$ |
(17,643,707 |
) |
Deemed dividends |
|
|
(506,477,007 |
) |
|
|
(263,254,718 |
) |
Net loss available to common stockholders, continuing operations |
|
$ |
(511,749,380 |
) |
|
$ |
(280,898,425 |
) |
Net income (loss) from discontinued operations |
|
|
10,877,530 |
|
|
|
(696,067 |
) |
Net loss available to common stockholders |
|
$ |
(500,871,850 |
) |
|
$ |
(281,594,492 |
) |
|
|
|
|
|
|
|
|
|
Denominator |
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares of common stock outstanding |
|
|
548,377 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
Loss per common share available to common stockholder - basic and diluted |
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
(933.21 |
) |
|
$ |
(280,898,425 |
) |
Discontinued operations |
|
$ |
19.84 |
|
|
$ |
(696,067 |
) |
Total basic and diluted |
|
$ |
(913.37 |
) |
|
$ |
(281,594,492 |
) |
|
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Diluted
loss per share excludes all dilutive potential shares if their effect is anti-dilutive. As of December 31, 2021 and 2020, the following
potential common stock equivalents were excluded from the calculation of diluted loss per share as their effect was anti-dilutive:
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
|
|
Year Ended December 31, |
|
|
|
2021 |
|
|
2020 |
|
Warrants |
|
|
54,280,658 |
|
|
|
467 |
|
Convertible preferred stock |
|
|
48,188,965 |
|
|
|
403 |
|
Convertible debentures |
|
|
2,877,783 |
|
|
|
33 |
|
Stock options |
|
|
26 |
|
|
|
26 |
|
|
|
|
105,347,432 |
|
|
|
929 |
|
|